Posted On: 01/25/2016 4:06:41 PM
Post# of 72443
AAAh Haaa I think this is what you are referencing.
"BEVERLY, MA--(Marketwired - January 19, 2016) - Cellceutix Corporation (OTC: CTIX) (the "Company"
, a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, is pleased to inform shareholders that the briefing book with data collected during the Phase 1 clinical trial of Kevetrin for various advanced solid tumors has already been submitted to the U.S. Food and Drug Administration (FDA). This briefing book submission is in advance of the FDA meeting to discuss the planned Phase 2 clinical trial of Kevetrin for advanced ovarian cancer. "
http://www.reuters.com/article/idUSnMKWtmqWCa...KW20160119
"BEVERLY, MA--(Marketwired - January 19, 2016) - Cellceutix Corporation (OTC: CTIX) (the "Company"
, a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, is pleased to inform shareholders that the briefing book with data collected during the Phase 1 clinical trial of Kevetrin for various advanced solid tumors has already been submitted to the U.S. Food and Drug Administration (FDA). This briefing book submission is in advance of the FDA meeting to discuss the planned Phase 2 clinical trial of Kevetrin for advanced ovarian cancer. " http://www.reuters.com/article/idUSnMKWtmqWCa...KW20160119
(0)
(0)Scroll down for more posts ▼
